Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related EYEG
Benzinga's Daily Biotech Pulse: Eli Lilly, Edge Therapeutics, BioXcel Report Positive Trial Results, 4 Stocks Debut
40 Biggest Movers From Friday
Related AMD
Jim Cramer Gives His Opinion On Advanced Micro Devices, Apache, Twilio And More
Earnings Season Off To Good, But Not Great, Start As Morgan Stanley Reports
Big Week Of Earnings For Chip Sector: Which Companies Are Set Up For The Biggest Moves (Seeking Alpha)

Noble Financial initiated coverage on Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) with a Buy rating. Eyegate Pharmaceuticals shares closed at $3.00 on Wednesday.

Analysts at Craig-Hallum initiated coverage on Advanced Micro Devices, Inc. (NASDAQ: AMD) with a Hold rating. Advanced Micro Devices shares closed at $2.80 on Wednesday.

Analysts at Sterne Agee CRT initiated coverage on Vail Resorts, Inc. (NYSE: MTN) with a Buy rating. Vail Resorts shares closed at $128.72 on Wednesday.

Analysts at FBR Capital initiated coverage on Education Realty Trust, Inc. (NYSE: EDR) with a Outperform rating. Education Realty Trust shares closed at $40.62 on Wednesday.

Jefferies initiated coverage on Eiger Biopharmaceuticals Inc (NASDAQ: EIGR) with a Buy rating. The target price for Eiger Biopharmaceuticals is set to $35. Eiger Biopharmaceuticals shares closed at $19.57 on Wednesday.

H.C. Wainwright initiated coverage on Viking Therapeutics Inc (NASDAQ: VKTX) with a Buy rating. The target price for Viking Therapeutics is set to $6. Viking Therapeutics shares closed at $1.42 on Wednesday.

Analysts at Argus Research initiated coverage on National Grid plc (ADR) (NYSE: NGG) with a Hold rating. National Grid shares closed at $70.62 on Wednesday.

Analysts at BMO Capital initiated coverage on Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) with a Market Perform rating. Vertex Pharmaceuticals shares closed at $91.31 on Wednesday.

Analysts at Janney Capital initiated coverage of Tokai Pharmaceuticals Inc (NASDAQ: TKAI) with a Buy rating. Tokai Pharmaceuticals shares closed at $7.75 on Wednesday.

Brean Capital initiated coverage of Intel Corporation (NASDAQ: INTC) with a Buy rating. The target price for Intel is set to $36. Intel shares closed at $32.08 on Wednesday.

Latest Ratings for EYEG

DateFirmActionFromTo
Nov 2017H.C. WainwrightMaintainsBuy
Apr 2016Noble FinancialInitiates Coverage onBuy
Nov 2015Maxim GroupInitiates Coverage onBuy

View More Analyst Ratings for EYEG
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (AMD + EDR)

View Comments and Join the Discussion!